Magaldrate
Description
Type: small molecule
Groups: withdrawn
Indication: Not Available
Accession Number: DB08938 ( DB08938)
Description: Magaldrate is an antacid drug used for the treatment of esophagitis, duodenal and gastric ulcers, and gastroesophageal reflux. Magaldrate has been discontinued in the US market.
Structure:
Prescription Products: Not Available
Generic Prescription Products: Not Available
Over the Counter Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Riopan Chewable Tablets 480mg | tablet | 480 mg | oral | 31-12-1994 | 31-07-2002 | Canada |
Riopan Sus 480mg/5ml | suspension | 480 mg | oral | 31-12-1993 | 19-07-2002 | Canada |
Riopan Suspension 480mg/5ml | suspension | 480 mg | oral | 31-12-1994 | 31-07-2002 | Canada |
Riopan Tab 480mg | tablet | 480 mg | oral | 31-12-1993 | 19-07-2002 | Canada |
Over the Counter Products:
Name | Dosage | Strength | Route | Marketing Start | Marketing End | Country |
Riopan Chewable Tablets 480mg | tablet | 480 mg | oral | 31-12-1994 | 31-07-2002 | Canada |
Riopan Sus 480mg/5ml | suspension | 480 mg | oral | 31-12-1993 | 19-07-2002 | Canada |
Riopan Suspension 480mg/5ml | suspension | 480 mg | oral | 31-12-1994 | 31-07-2002 | Canada |
Riopan Tab 480mg | tablet | 480 mg | oral | 31-12-1993 | 19-07-2002 | Canada |
International Brands
- No Brands
Brand Names
- No Brands
Brand Mixtures
Brand Name | Ingredients |
---|---|
Riopan Sus 480mg/5ml | Magaldrate |
Riopan Tab 480mg | Magaldrate |
Riopan Suspension 480mg/5ml | Magaldrate |
Riopan Chewable Tablets 480mg | Magaldrate |
Brand Name | Ingredients |
---|---|
Riopan Sus 480mg/5ml | Magaldrate |
Riopan Tab 480mg | Magaldrate |
Riopan Suspension 480mg/5ml | Magaldrate |
Riopan Chewable Tablets 480mg | Magaldrate |
Categories
- No Category
Pharmacology
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Aluminium oxide: absorbed Al ions are eliminated in the urine (0.1-0.5 mg of Al in aluminium-containing antacid is absorbed from standard daily doses of antacid) while insoluble or poorly absorbed Al salts in the intestines are excreted through the feces. Magnesium oxide: absorbed Mg ions (up to 30%) are eliminated in the urine, unabsorbed is excreted in the feces.
Half life: Not Available
Clearance: Not Available
Toxicity: Not Available
Affected organisms
- Not Available
SNP Mediated Adverse Drug Reactions
- Not Available
Pharmacoeconomics
- Not Available
Packagers:
- Not Available
Dosage forms
Form | Route | Strength |
---|---|---|
Suspension | oral | 480 mg |
Tablet | oral | 480 mg |
Form | Route | Strength |
---|---|---|
Suspension | oral | 480 mg |
Tablet | oral | 480 mg |
Prices
Unit description | Cost | Unit |
---|
Unit description | Cost | Unit |
---|
Patents
Country | Patent Number | Approved | Expires (estimated) |
---|
Interactions
Drug | Interaction |
---|
Drug | Interaction |
---|
Food Interactions:
- Not Available
Taxonomy
Super Class: Not Available
Class: Not Available
Sub Class: Not Available
Direct Parent: Not Available
Alternative Parents:
- Not Available
substituent:
- Not Available
References
General Reference: # Kurtz W: [A layered lattice antacid with long-term effectiveness. Profile of action and safety exemplified by magaldrate]. Fortschr Med. 1993 Feb 28;111(6):93-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/8462913 # Varas Lorenzo MJ, Lopez Martinez A, Gordillo Bernal J, Mundet Surroca J: [Comparative study of 3 drugs (aceglutamide aluminum, zinc acexamate, and magaldrate) in the long-term maintenance treatment (1 year) of peptic ulcer]. Rev Esp Enferm Dig. 1991 Aug;80(2):91-4. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/1790087
External Links:
Resource | Link |
---|---|
Drugs.com | http://www.drugs.com/international/magaldrate.html |
Resource | Link |
---|---|
Drugs.com | http://www.drugs.com/international/magaldrate.html |
ATC Codes:
- Array
AHFS Codes:
- Not Available
MSDS: Download